Antituberculous drugs in kidney transplant recipients treated with cyclosporine.
Peschke
B
B
Abteilung für Nephrologie, Klinikum der Johann Wolfgang Goethe-Universität, Main, Germany.
Ernst
W
W
Gossmann
J
J
Kachel
H G
HG
Schoeppe
W
W
Scheuermann
E H
EH
D000368:Aged; D000995:Antitubercular Agents / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016572:Cyclosporine / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004347:Drug Interactions; D004977:Ethambutol / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D016572:Cyclosporine; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin